Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02024698 · ClinicalTrials.gov registry record · NA
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT02024698 is a NA study that has completed, run by CooperVision. The registered enrollment target is 43 participants.
The verdict
NCT02024698, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The objective of this study is to compare the clinical performance of ProClear 1-Day versus 1-Day Acuvue Moist each for one week of daily disposable wear.
Interventions
- DEVICE etafilcon A
- DEVICE omafilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02024698
The ClinicalTrials.gov registry entry for NCT02024698 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which etafilcon A is the first listed.
NCT02024698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02024698 about?
NCT02024698 is a clinical study titled "Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist". The objective of this study is to compare the clinical performance of ProClear 1-Day versus 1-Day Acuvue Moist each for one week of daily disposable wear.
What is the current status of trial NCT02024698?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2014-01. Estimated completion is 2014-03.
What interventions are being tested in trial NCT02024698?
The interventions under investigation include: etafilcon A (DEVICE), omafilcon A (DEVICE).
Who is sponsoring clinical trial NCT02024698?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.